Progyny, with a low ROCE score of 9.2%, underscores promisin...

Progyny, with a low ROCE score of 9.2%, underscores promising fundamentals following its foray into profitability. Having offered a notable 27% to shareholders over three years, its developing factors necessitate a deeper analysis for future investment opportunities.